Pharmaceuticals & Drugs

ERIS

Eris Lifesciences Ltd.

Wait and Watch

Early Trend
Stage 2 VCP active Vol compression Handle

Setup readiness

Early Trend

Pivot Levels
₹1436.1-1537.7
Support Level
₹1463.4
Resistance
₹1836.0
Risk Distance
4.8% to stop

Reference levels for educational study only. Not a recommendation to buy or sell.

RS
45.0
ADX
22.0
Vol
53.0

Swing Edge Intelligence

Structured setup analysis · research only

Setup status · Developing setup

Some constructive elements are present, but leadership and breakout quality remain mixed.

Relative strength Neutral
Breakout readiness High
Accumulation Constructive

Bullish factors

  • Moderate distance from 52w high (-23% below).
  • OBV leadership while price lags — accumulation divergence.
  • Relative strength remains below leadership thresholds.
  • Price is approaching the pivot zone.
  • 1 prior pivot rejection in last 60d (-8 pts).
  • ATR shrinking 4 consecutive weeks — coil tightening precisely.
  • RSI 62 — ideal setup zone.
  • Handle formation — consolidation after the prior advance.
  • Price has built a constructive advance from the 52-week low.
  • Volume flow suggests quiet institutional accumulation.

Risk factors

Overall view

The setup is still developing — leadership and trend alignment need further confirmation.

Size this trade

Setup research

ERIS — trend, RS & risk snapshot (not a trade recommendation)

Signal · context · invalidation · risk · skip reasons — research only

Positives

Coiled at the pivot — breakout trigger is imminent

  • Volume drying up into the base — supply fading
  • Handle formed after the prior advance
  • Confirmed Stage 2 uptrend

Flagged today

Context & regime

  • Market regime Mixed / range-bound
  • Trend stage Stage 2 — tradable
  • Sector Mid-pack (#20/40)
  • Relative strength Lagging (RS 45)
  • Trend strength Weak (ADX 22)

Negatives

This idea is wrong below ₹1463.4 (-0.3% away)

Base / stop support breaks — the swing thesis is wrong below here

  • Stop / base low₹1463.4
  • Pivot — failure re-entry below₹1530.0

Risk distance

4.8% to stop
1.9× ATR
4.0× R:R
19.4% reward

Risk ≈ ₹74.29/share from entry ₹1537.7.

No major skip flags detected from current scanner data.

Setup metrics Latest scan

ERIS Technical Analysis & Swing Setup

Grouped structure, momentum and risk from the latest research scan.

Volume Profile bullish
POC₹1376.67
VAH₹1443.33
VAL₹1336.67
Vol above POC59.4%
Institutional Activity — Moderate Accumulation
Avg cost basis₹1445.14
Acc zone₹1303.9–1495.0
Accumulation Sessions4
CMF0.11

Structure

Trend / stage
Stage 2 (Early)
Stage 2
Weekly trend
Above 30-wk MA (flat)
Above 30W
RS rank
45.0
Weakening
ADX
22.0
Weak

Momentum

RSI
62.0
Strong
Recent move (10d / 20d)
+6.8% / +8.0%
Neutral
Volume quality
53.0
Building
Relative strength
Lagging
Neutral

Risk

Failure risk
34.0
Moderate
ATR % / day
2.5%
Moderate
Distribution
1 day(s)
Accumulation
Volatility
4 VCP
Contracting
More scanner fields
Sector RS 0.0%
Base 16w · 21.6%
VCP waves 4x
Vol dry-up Yes
Avg value ₹20.5 Cr
Failure flags Overhead supply, RS laggard

ERIS Support & Resistance Levels

AI insights

AI Insights

Generated with AI

These insights are AI-generated to support your research process and should not be treated as investment advice or a recommendation to buy or sell securities.

Sign in to unlock AI Insights

Personalised swing trade analysis powered by Gemini AI

Pattern context 52w · setup · flow

52-week range

Stage-2 ideal band  ·  Early recovery

Pattern highlights

Loading…

Pattern signals from the latest scan

Smart money flow

Last 60 sessions · accumulation vs distribution

Loading…
Session flow 60 trading days
OBV trend On-balance volume · same window
·
Accumulation Distribution Neutral
Setup intelligence Overhead · VCP · radar · risk

Overhead supply

Resistance ceiling above current price

Loading…

Chase / failure risk

Honest read on exhaustion & extended moves

Loading…

Base / VCP coil

Depth, contractions & pivot distance

Loading…

Setup quality radar

Shape of the setup in one view

Loading…
Peer comparison Sector peers

Sector Peer Comparison

Loading sector peers…

Fetching peer data…
ERIS FAQ Common swing-trading questions

Frequently asked questions about ERIS

What are the screener observations for ERIS?

On Swing Edge's swing-setup framework, Eris Lifesciences Ltd. (ERIS) currently grades B — workable setup. Coiled at the pivot — breakout trigger is imminent. Flagged today. This is educational research, not investment advice.

What are ERIS's support and resistance levels?

For ERIS, near-term support sits around ₹1,463.4 (the base/stop zone); overhead resistance is around ₹1,530.0 (the breakout pivot); the next resistance above is ₹1,836.0. This is educational research, not investment advice.

What is the breakout / pivot level for ERIS?

The breakout pivot for ERIS is around ₹1,530.0. Price is about 4.6% below the pivot and still building toward it. A breakout is typically confirmed on a close above the pivot with above-average volume. This is educational research, not investment advice.

Is ERIS above its 50-day and 200-day moving averages?

Yes — ERIS is in a confirmed Stage 2 uptrend, trading above its rising 50- and 200-day moving averages, the zone where swing setups tend to work best. This is educational research, not investment advice.

How strong is ERIS versus the market (RS rank)?

ERIS has a relative strength (RS) rank of 45 out of 100 versus the NSE universe, making it lagging the broader market on relative strength. Trend strength (ADX) reads 22, indicating a building trend. This is educational research, not investment advice.

Answers are generated from Swing Edge's latest scan data and are for research only — not investment advice.

Prices and day-change figures use the last daily close from scan data dated 2026-06-25 — not live intraday NSE quotes.